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Abstract
Background: There is sufficient and consistent evidence that alcohol use is a causal risk factor for
injury. For cannabis use, however, there is conflicting evidence; a detrimental dose-response effect
of cannabis use on psychomotor and other relevant skills has been found in experimental
laboratory studies, while a protective effect of cannabis use has also been found in epidemiological
studies.
Methods: Implementation of a case-crossover design study, with a representative sample of
injured patients (N = 486; 332 men; 154 women) from the Emergency Department (ED) of the
Lausanne University Hospital, which received treatment for different categories of injuries of
varying aetiology.
Results: Alcohol use in the six hours prior to injury was associated with a relative risk of 3.00 (C.I.:
1.78, 5.04) compared with no alcohol use, a dose-response relationship also was found. Cannabis
use was inversely related to risk of injury (RR: 0.33; C.I.: 0.12, 0.92), also in a dose-response like
manner. However, the sample size for people who had used cannabis was small. Simultaneous use
of alcohol and cannabis did not show significantly elevated risk.
Conclusion: The most surprising result of our study was the inverse relationship between
cannabis use and injury. Possible explanations and underlying mechanisms, such as use in safer
environments or more compensatory behavior among cannabis users, were discussed.
Background
There is sufficient evidence indicating alcohol use as a
contributing causal factor for injury [1,2]. This evidence
comes from case-control (e.g., [3,4]), case-crossover (e.g.,
[4-6]), and experimental studies [7,8]. While most of the
research has been conducted on traffic injuries, there is
also ample evidence for the role of alcohol in other mech-
anisms of injuries, including clear biological pathways via
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ioural consequences, even at relatively low levels of con-
sumption [8].
Meanwhile, the causal relationship between cannabis use
and injury is less clear. While there is consistent evidence
from laboratory studies of a dose-response effect of canna-
bis use on psychomotor and other relevant skills [9-13],
the epidemiological evidence is still inconsistent [14].
Most of this research has been conducted in the area of
driving impairment from the influence of cannabis (but
see [15]). In a major review of 17 studies from around the
world, Macdonald and colleagues [16] reported that the
average proportion that tested positive for cannabis use
across studies was 7.8% for fatally injured drivers (ranging
from 1.4% to 27.5%) and 11.9% for non-fatally injured
drivers (ranging from 5% to 16.9%). However, as canna-
bis screening tests may show positive results for days or
weeks after a single usage [17,18], clearly long after the
drug's period of influence over psychomotor behaviour
has ended [18], such data are of limited value when
attempting to assess the actual causal impact of cannabis
use on collision risk. Moreover, as control conditions
were often not included in theses studies, the mere pres-
ence of cannabis in a certain proportion of people injured
in traffic collisions did not establish causality. In addition
there is a lack of consensus among studies that have
employed control groups or conditions, as some suggest a
causal relationship between cannabis consumption and
injury, while others do not [19-21].
Furthermore, in cases where cannabis was established as a
risk factor for fatal injury, there were problems with the
control group, such as in the study of Dussault and col-
leagues [20] where only 49.6% of controls agreed to pro-
vide consent for a urine sample for analysis. Substance use
and injury studies generally have the difficulty defining an
adequate control group (e.g., non-injured as controls for
injured [22]). One way of overcoming this problem is
responsibility analysis, which is based on the premise that
if cannabis use increases collision risk, than the drug
should be more likely to be detected in drivers judged
responsible for collisions, as compared to other drivers
[23]. However, the overall results of responsibility analy-
sis have been mixed [10,24-26].
In summary, the aforementioned laboratory studies have
indicated the causal influence of cannabis in psychomo-
tor skills impairment. While it is not clear to what degree
this effect is relevant in real-life situations, it has been pro-
posed that people driving under the influence of cannabis
may actually recognize the impairment and compensate,
thus becoming more cautious in real-life driving situa-
tions [10,24]. Nevertheless, as is the case for alcohol, there
should be limits on such compensation [27,28].
The combination of alcohol and cannabis use for injury is
potentially an important public health question for two
reasons. First, given the substantially increase in preva-
lence of cannabis use in Switzerland, as in many other
countries over the past years, the prevalence of combined
use may have also increased likewise. Second, combined
alcohol and cannabis use may result in multiplicative,
rather than additive, risks. Some studies in the area of traf-
fic injuries have indicated such a multiplicative effect
(e.g., [21]), but as with other research in this field, find-
ings have been inconsistent.
The main objective of this research is to assess the poten-
tial impact of alcohol and cannabis use on risk for injury.
Specifically, we hypothesize that:
• The higher the alcohol use, the higher the subsequent
risk of injury.
• Cannabis use will increase the subsequent risk of injury.
• Combined use of alcohol and cannabis will result in a
higher risk of injury than expected in a purely additive
model.
The present study was planned to expand on existing
research in several ways:
• We did not restrict ourselves to traffic injury, but
included all categories of injury.
• We used case-crossover design to avoid problems in
comparability of cases and controls. This methodology
uses each injured person as his/her own control, by assess-
ing the relevant exposure immediately before the event, as
well as of the same period one week prior.
Methods
Sample and design
This study used a case-crossover design, with respondents
serving as their own controls [29,30]. A representative
sample of injured patients (N = 486; 332 men; 154
women) treated in the Emergency Department (ED) of
the Lausanne University Hospital (CHUV; Switzerland)
was collected. The CHUV is the main public hospital in
the Lausanne area (pop. 200,000) and is thus expected to
process the majority of injured patients. Alternative
trauma care consisted of private medical practices and
medical day care centers, both of which were used for
medical rather than trauma reasons due to insufficient
infrastructure. Given this situation, all severe and com-
mon injuries that occur in the Lausanne area expect to be
diagnosed and possibly treated at the ED of the CHUV.
For the collection of data, 270 out of more than 900 four-
hour time slots were randomly chosen during five one-Page 2 of 9
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All hours (24/24) of all days (7/7) of the week were
included in the sampling. Criteria for inclusion were: a)
being aged sixteen or older, b) sufficient understanding of
the French language, c) attendance of the ED within
twenty-four hours of the occurrence of injury, and d) no
attendance of the ED for follow-up care. According to
administrative statistics, 1,165 injured patients were
admitted to the ED during the field phase. Among them,
391 (33.6%) were not eligible according to the inclusion
criteria, i.e. age or language (n = 87), late attendance or
follow-up care (n = 304). Other reasons for non-inclusion
included vetoes from the medical staff (i.e. patients very
severely injured or accompanied by police or security
staff, n = 26); death after admission (n = 4); no possibility
for informed consent (i.e. patients with a degenerative
brain disorder, n = 37); unrecorded reason (n = 1). Of the
remaining 706 eligible patients, 43 could not be inter-
viewed due to a rapid transfer to other wards, out of the
ED, where it was impossible to conduct interviews. In
addition, 115 could not be interviewed due to interviewer
work overload or ongoing medical care. Three patients
refused any collaboration and 57 actively refused to par-
ticipate in the study (8.1% of total eligible sample). Thus,
non-response (response rate = 69.1%) was due mostly to
organizational issues and refusal was rare (the coopera-
tion rate excluding those not contacted due to interviewer
work overload or ongoing medical care was 82.6%).
Finally, two patients had incomplete data on either alco-
hol or cannabis use and were thus excluded from the anal-
ysis. As a result the final sample included N = 486
patients. The study was approved by the Ethics Committee
for Clinical Research of the Lausanne University Medical
School (No. 96/05).
Measures
The case-crossover design used the six-hour period preced-
ing the injury event as the case period and the same six-
hour period of exactly one week prior to the event as the
control period. The questionnaire followed the protocol
developed by the WHO Collaborative Study Group on
Alcohol and Injuries [31], with adaptations for questions
on cannabis use. Alcohol consumption within the six-
hour periods was measured in drinks of different con-
tainer sizes (e.g., small bottle of beer = 0.3 l or a can of
beer = 0.5 l) for beer, wine, champagne, aperitifs, spirits,
alcopops (lemonade drinks premixed with spirits), and
mixed drinks such as cocktails. The number of drinks
along with their respective container sizes were converted
into grams of pure ethanol using the official conversion
rates of the Swiss Alcohol Board (11 vol. % for wine, 4.8
vol. % for beer and 40 vol.% for spirits) and summed
across beverages. Alcohol use was then broken down into
four categories: 1) no use; 2) less than 20 grams for men,
respectively less than 10 grams for women; 3) 20 to 40
grams and 10 to 30 grams (men/women); and 4) more
than 40 grams, respectively more than 30 grams (men/
women). Cannabis use within the six-hour periods (case
and control) was measured through a single quantity
question and similarly broken down into four categories:
1) no use; 2) "less than a pipe or joint"; 3) "about a pipe
or joint"; and 4) "more than a pipe or joint".
In addition, self-reports were corroborated with alcohol
exposure measured in blood samples from a consenting
sub-sample. Only those individuals (n = 356) who arrived
within the six-hour period of injury were approached, of
which 126 gave permission and were tested. Two sets of
samples for blood plasma and serum were taken and
stored immediately in a refrigerator in the ED, rapidly fro-
zen later that same day in the University Institute of
Forensic Medicine, and analysed within the month. Levels
of ethanol in the blood or breath and markers of ethanol
use in the serum were tested (results on markers were not
used in this current study).
Cannabis use was detected through testing for three blood
components: tetrahydrocannabinol (THC), and its
metabolites 11-hydroxy-tetrahydrocannabinol (11-OH-
THC) and carboxy-tetrahydrocannabinol (THCCOOH).
A person tested positive for cannabis use if one of the
three measures exceeded the limit of detection of 0.5 ng/
ml. It should be noted that we were well aware that posi-
tive results for the metabolite THCCOOH only indicates
usage at some point in the previous few weeks (12), and
is not an indicator of possible impairment at the time of
the injury [32]. Risk relationships were based on self
reported cannabis use.
Statistical analysis
A matched-pair case-crossover design was used for the sta-
tistical analysis [30]. The estimate of a relative risk with
dichotomous outcomes is the ratio of discordant pairs of
a case (period) by control (period) in a 2 by 2 table, i.e. a
division of the number of users in the six-hour case period
(that were not so in the control group) by the number of
users in the week prior (control period) that were not
users in the six hours prior to injury (case period). This
estimator is equivalent to the estimator obtained in a con-
ditional logistic regression where the strata are the indi-
viduals [33]. Conditional logistic regression was then
used to obtain confidence intervals, this also permitted
the estimation of more complex dose-response (levels of
substance use) and interaction models (joint effect of
alcohol and cannabis use).
Results
The distribution of injuries in our sample of 486 patients
included 45% fall injuries, 15% motor vehicle injuries,
9% intentional injuries, and 30% other injuries (1% miss-Page 3 of 9
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hour period prior to injury (case period) than in the cor-
responding six-hour period in the previous week (control
period). Consumption levels among users were on aver-
age, higher for the case period than for the control period
(Table 1). For cannabis, fewer people reported use prior to
injury (case period) than in the control period, with the
level of use among users, on average, lower in the case
period. The same was found for cannabis use in combina-
tion with alcohol use. It should be noted that only 14 men
and no women of our sample had used cannabis before
the injury.
As can be seen in Table 2, any alcohol use prior to injury
was associated with an increased risk for injury (but did
not reach the 5% significance level for women). Relative
risks increased with a dose response relationship with
increasing alcohol use in both sexes. However, only high
alcohol use in women, and medium and high alcohol use
in men were significantly different from no alcohol use.
Conversely, cannabis use was associated with a signifi-
cantly lowered risk for injury (Table 3). Whereas the risk
for injuries associated with the use of less than a pipe or
joint's worth were not significantly different from the one
associated with no use, relative risks decreased with
increasing levels of use and were significantly lower than
1.
As shown in Table 4, alcohol was the major risk factor for
injury and remained significant even after adjusting for
cannabis use and the interaction between alcohol and
cannabis use. The prevalence of users of both alcohol and
cannabis was low (i.e. 1.0% in case period and 1.9% for
the control period, see table 1). The findings in Table 4
indicate that cannabis use in combination with alcohol
use did not increase risk for injury.
We also asked about the use of the following substances,
other than alcohol and cannabis, in the period prior to the
injury: cocaine, benzodiazepines or drugs with similar
properties, the latter was based on a list of the 25 most
common of these medicines in Switzerland; as well as
added an open-ended question on (other) drugs, which
resulted in mentions of methadone, ecstasy, and other
psychotropic pharmaceuticals. 9% of the sample indi-
cated use of such drugs. The proportions were 12% in the
group with alcohol use without cannabis use, 0% in the
group with cannabis use without alcohol use, and 20% in
the group with combined use of alcohol and cannabis.
Regarding the validity of self-reporting alcohol use,
patients were ten times more likely to have self-reported
alcohol use while having negative blood alcohol concen-
trations, compared with having a positive blood alcohol
concentration while self-reporting no alcohol use (for
details see [34]). With cannabis use, 113 individual had
negative matches (no self reported use, no positive blood
test). Three individuals (of 14) with self-reported use in
the case period provided blood samples, 2 of which were
positive. Of the remaining 10 individual's blood samples,
8 were positive; of which 3 reported use in the control
period, leaving 5 with a positive blood screen and no self-
reported use in either the case or control period. There
were also 2 who reported cannabis use in the control
period but were negative on their blood samples. These
data did not give strong support for the hypothesis of
deliberate denial. It should be noted that the 5 individu-
als, even with positive screens and no use in either the case
or the control period, were were not necessarily persons
who denied use when they had in fact used. Cannabis use
in the blood can be detected from usage prior to the refer-
ence period used here, and of course, there may have been
usage in between.
Discussion
The results of our study corroborate research showing the
detrimental effect of alcohol use on injury. The results for
cannabis use were quite surprising, as they were associated
with less risk of injury, which seems to contradict the lab-
oratory studies cited above, as well as opposes the obser-
vations on alcohol use. While these findings are thus more
in line with other epidemiological studies showing no
effect of cannabis use, possibly even a protective one (e.g.,
[32,35]), they are limited by the small sample size of can-
nabis users and do not necessarily contradict findings
from laboratory studies. One possibility is that persons
driving under the influence of cannabis become more
cautious in real-life driving situations than they would in
the laboratory [10,24], e.g., by avoiding potentially risky
situations [10]. Furthermore, the present study did not
only look at traffic casualties, but also included other
mechanisms for injury with potential links to cannabis
use that are different from those for traffic injuries.
The compensation hypothesis is unlikely to be the only
explanation of our results. First, as is the case for alcohol,
there should be limits for such compensation [27,28]. The
present study in fact indicated a 'protective effect' of can-
nabis use in a dose-response relationship. Second, the
combined intake of alcohol and cannabis failed to show
an increased risk for injury when compared with unac-
companied alcohol use, as should be expected [21].
Nonetheless, the relative risk was below even 1 when
compared with individuals that abstained from both sub-
stances in the six-hour period prior to injury. Third, com-
pared with other studies (e.g., [16,21]) only very few (i.e.
2.9% of the present sample) had consumed cannabis in
the six-hour period prior to injury. This seems to be quite
low given the fact that Switzerland has one of the highestPage 4 of 9
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Table 1: Alcohol- and cannabis use characteristics 6 hours prior to injury and in the control period
men (n = 332) women (n = 154) total (n = 486)
Drinking
Just prior to injury yes 28.3 16.9 24.7
A week prior to injury yes 19.6 11.0 16.9
Drinking levels among user
Just prior to injury low 30.9 30.8 30.8
medium 21.3 26.9 22.5
high 47.9 42.3 46.7
A week prior to injury low 51.7 50.0 51.3
medium 20.0 31.3 22.4
high 28.3 18.8 26.3
Cannabis use
Just prior to injury yes 4.2 0.0 2.9
A week prior to injury yes 6.3 1.9 4.9
Use levels among user
Just prior to injury < 1 joint/pipe 42.9 n.a. 29.3
1 joint/pipe 35.7 n.a. 24.4
> 1 joint/pipe 21.4 n.a. 14.6
A week prior to injury < 1 joint/pipe 14.3 0.0 12.5
1 joint/pipe 42.9 33.3 41.7
> 1 joint/pipe 42.9 66.7 45.8
Joint use
Just prior to injury none 69.0 83.1 73.5
alcohol only 26.8 16.9 23.7
cannabis only 2.7 n.a. 1.9
both 1.5 n.a. 1.0
A week prior to injury none 76.5 87.7 80.0
alcohol only 17.2 10.4 15.0
cannabis only 3.9 1.3 3.1
both 2.4 0.6 1.9
Alcohol consumption:
low: less than 20 grams for men and 10 grams for women;
medium: 20 to 40 grams for men, 10 to 30 grams for women;
high: more than 40 grams for men, more than 30 grams for women;
n.a. not applicable; no cannabis use 6 hours prior to injury among women.
BMC Public Health 2009, 9:40 http://www.biomedcentral.com/1471-2458/9/40cannabis use prevalence rates in the world (see [36] for
students, and [37] for adults), and therefore may point to
the possibility that Swiss cannabis users take precautions
to avoid injuries while using cannabis.
Another possible explanation is that when compared to
alcohol consumption, cannabis is consumed in relatively
safer, low risk environments (e.g. at home, private loca-
tions, not public such as bars or while 'going out'), inde-
pendent of whether also it is consumed with alcohol.
Future studies should look at the environment of predom-
inant cannabis usage and whether the place of consump-
tion (e.g. at home, during special occasions) is
differentially associated with risks of injuries. The number
of cannabis usage cases in the present study was simply
too small, to permit a stratified analysis by place of con-
sumption.
As the main results of the study are based on self-reported
measures of cannabis use, there may have been a deliber-
ate denial of illicit behaviour. Although this may explain
the small prevalence, it is unlikely to explain a protective
association with injury. It also begs the question of why
individuals would deny cannabis use before an injury, but
admit use in the week prior (which is needed to result in
a relative risk below 1)? As shown above, there is not a lot
of indication for deliberate denial. However, there may be
other memory effects, e.g., the ability for recall may have
been impeded by alcohol and cannabis use, especially for
the period of one week before the injury. Recall errors may
have also particularly affected the estimates in case-cross-
over studies (e.g., overestimation of relative risks due to
the underestimation of use in the control period that is
retrospectively farther away in time [38]), but would not
explain why cannabis use had a protective effect.
While the participation rate was relatively high (8% refus-
als), we cannot exclude the possibility, that exclusion may
have been associated with exposure. Another limitation of
our research was the small sample size for cannabis use,
and as a result, we should be cautious with conclusions.
Clearly, more research is needed, epidemiological studies
in particular. Roadside surveys in the tradition of Borken-
stein and colleagues [3] should be conducted more sys-
tematically to allow for a better examination of the causal
effects of cannabis use in traffic injury. In such studies, not
only is the blood alcohol concentration in participants of
traffic injuries measured, but a random sample of compa-
rable traffic participants is measured as well. This allows
for the establishment of relative risk estimates. However,
even if such studies yield significant relative risks for
injury as a consequence of cannabis use, this does not nec-
essarily demonstrate sufficient evidence for the public
health importance of the problem. It may be that
although cannabis is causally connected to traffic injury,
the importance of this risk factor is small due to a low
Table 2: Relative risk estimates for any alcohol use and its dose-response relationship
Women Men Total
RR 95% CI lower 95% CI upper RR 95% CI lower 95% CI upper RR 95% CI lower 95% CI upper
drinking status 6 
hours before 
injury status
No (reference) 1 1 1
Yes 2.50 0.97 6.44 3.23 1.73 6.02 3.00 1.78 5.04
dose response 
(women/men)
no alcohol use 
(reference)
1 1 1
Low 1.00 0.29 3.45 1.49 0.66 3.36 1.37 0.69 2.70
medium 6.41 0.76 54.20 2.91 1.16 7.32 3.14 1.41 6.97
High 25.26 1.66 383.62 7.80 2.86 21.26 8.97 3.55 22.69
Alcohol consumption:
low: less than 20 grams for men and 10 grams for women;
medium: 20 to 40 grams for men, 10 to 30 grams for women;
high: more than 40 grams for men, more than 30 grams for women.Page 6 of 9
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factors, such as drinking and driving. Thus, attributable
fractions may be small. Of course, the public health
importance may differ in regions with higher prevalence
of cannabis use. One of the more interesting research con-
tinuations in this area would be to replicate this study in
regions with higher prevalence of cannabis use and higher
incidence of injury (e.g., some parts of Africa or the Carib-
bean).
In conclusion, we need a more systematic exploration of
the relationships between cannabis use and other forms
of injury than traffic injuries. There are some indications
of cannabis use having a negative biological link to aggres-
sion [39], hence many categories of injuries may be differ-
entially impacted by cannabis as compared to alcohol.
These relationships should be studied in real life settings
and not only in the laboratory, as other factors such as
deviance or stigmatization may play a role.
Public health researchers tend to disregard subjective
reports of cannabis users, seemingly indicating that they
are more cautious and avoid risky situations subsequent
to use (e.g., [40]). However, given the numerous reports
on different mechanisms of injury, we should take these
reports more seriously and should start exploring more
systematically which situations involving cannabis use are
associated with increased or decreased risks of injury.
Such research could not only shed light on important
interactions between social and biological determinants
of behaviour, but could also contribute to better prevent-
ing cannabis-related harm.
Conclusion
This study indicated a 'protective' effect of cannabis use on
injury incidence, in a dose-response relationship, whereas
alcohol use showed a detrimental effect. Cannabis use in
combination with alcohol, did not increase risk compared
to alcohol use alone. Clearly, the findings are not suffi-
cient for calling change in legal limits for cannabis use e.g.
in road traffic laws, as laboratory studies have conversely
shown that cannabis use causes impairment of psycho-
motor skills. The findings do call, however, for a more
attentive analysis of the environment in which cannabis
Table 3: Relative risk estimates of any cannabis use prior to injury and dose response estimates
RR 95% CI lower 95% CI upper
cannabis use
no 1
yes 0.33 0.12 0.92
dose response
no use 1
less than 1 pipe or joint 1.45 0.34 6.23
1 pipe or joint 0.11 0.01 0.89
more than 1 pipe or joint 0.03 0.00 0.44
There were no women using cannabis in the 6 hours prior to injury and only 3 women a week ago. Therefore, only results for the total sample 
were reported
Table 4: Relative Risk estimates for alcohol and cannabis use 6 hours prior to injury
RR 95% CI lower 95% CI upper
no use 1.00
alcohol use only 3.08 1.77 5.34
cannabis use only 0.37 0.10 1.43
joint use of alcohol and cannabis 0.71 0.12 4.26
There were no women using cannabis in the 6 hours prior to injury and only 3 women a week ago. Therefore, only results for the total sample 
were reportedPage 7 of 9
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which may be associated with avoiding situations with an
increased risk of injuries.
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